Resectable/Potentially Resectable NSCLC
1 clinical trials · Condition
◉ Watch Resectable/Potentially Resectable NSCLC
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC (NCT06243679) | Xiangya Hospital of Central South University | 2020-07-01 |
Track Resectable/Potentially Resectable NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.